Evaluating Muscle Function After Ankle Surgery
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients who are forced to rest or reduce activity as a result of illness, injury, or surgery often experience resulting muscle weakness. This study will evaluate muscle features and muscle strength in patients who are recovering from surgery for broken ankles. The goal of this study is to improve the recovery of muscle function and overall ability after prolonged periods of ankle inactivity due to surgery.
| Condition | Intervention |
|---|---|
|
Muscle Atrophy Muscle Weakness Fractures |
Procedure: Physical Therapy |
| Study Type: | Observational |
| Study Design: | Additional Descriptors: Convenience Sample Observational Model: Natural History Time Perspective: Longitudinal Time Perspective: Prospective |
| Official Title: | Restoration of Muscle Function During Rehabilitation |
| Estimated Enrollment: | 30 |
| Study Start Date: | September 1995 |
| Estimated Study Completion Date: | August 2000 |
Many physiological conditions are associated with muscle weakness and can affect movement. This study will investigate which metabolic and morphological features of skeletal muscle are uniquely altered during the course of rehabilitation and how they affect muscle function and performance in daily ambulatory activities. This study will also examine how well the commonly used assessment measures reflect actual muscle capacity. Finally, because there is evidence that activity does not affect all fiber types uniformly, fiber-type specific metabolic and morphological measures will be performed.
Participants in this study will have had an ankle injury that has been treated surgically (Open Reduction Internal Fixation, or ORIF) followed by 5 to 10 weeks of cast immobilization. Following initial baseline measurements made after 1 week of re-ambulation, participants are enrolled in a 10-week rehabilitation program that focuses on restoration of both muscle strength and endurance. Assessments are made at Weeks 5 and 10 and include 31P-Magnetic Resonance Spectroscopy (MRS), Magnetic Resonance Imaging (MRI), muscle biopsy, and muscle function and functional performance tests. 31P-measurements monitor changes in the in vivo metabolic characteristics of skeletal muscle. 3D-MRI procedures will be used to quantify the maximal muscle cross-sectional area and total muscle volume. Muscle endurance and strength will be measured using an isokinetic dynamometer. Functional performance tests consist of self-selected walking pace, power for ascending and descending stairs, and toe raises while standing on one foot.
Nine participants (six patients and three control volunteers) will be studied each year. Control volunteers are submitted to the same measurements at similar time intervals in order to assess variability over time.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 5 to 10 weeks of cast immobilization following surgery (ORIF) for mallerolar fracture
Exclusion Criteria:
- Pregnant or breastfeeding
- Severe claustrophobia
- MRI incompatible metal implants (e.g., pacemaker)
- Diabetes or peripheral neuropathies
- Bleeding disorders
Contacts and Locations| United States, Pennsylvania | |
| MMRRCC, University of Pennsylvania | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Principal Investigator: | Krista Vandenborne, Ph.D., P.T. | University of Pennsylvania, Department of Physiology |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT00060970 History of Changes |
| Other Study ID Numbers: | R29HD33738 |
| Study First Received: | May 16, 2003 |
| Last Updated: | June 23, 2005 |
| Health Authority: | United States: Federal Government |
Keywords provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):
|
Disuse atrophy Ankle fracture Exercise, therapy |
Cast immobilization Deconditioning Sarcopenia |
Additional relevant MeSH terms:
|
Asthenia Fractures, Bone Muscular Atrophy Muscle Weakness Paresis Atrophy Signs and Symptoms Wounds and Injuries |
Neuromuscular Manifestations Neurologic Manifestations Nervous System Diseases Pathological Conditions, Anatomical Muscular Diseases Musculoskeletal Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on June 17, 2013